NEWS IN BRIEF MS Pharma acquires Genepharm, expands chronic disease portfolio 23-Apr-2019 By Vassia Barba Jordan-based MS Pharma announces the acquisition of the Greek generic manufacturer Genepharm, aiming to add cardiovascular, CNS and oncology products to its portfolio.